Subscribe Now!

Understand Pharma Sector in Detail - Pharma Primer

-
"Get ready for your comprehensive guide to understanding the fundamentals and specifics of the Indian Pharma Sector."
Pharmaceutical Industry

The following article provides an overview of the Indian Pharmaceutical Industry, aiming to familiarize readers with the terminology and jargon used in the industry. It briefly touches upon terms such as API, Intermediates, CDMOs/CRAMs, PARA Filings, Innovator drugs, Generic drugs, and life cycle development.

The Indian pharmaceutical market is unique in several ways. Branded generics make up 70 to 80% of the retail market, and India is the largest exporter of generic drugs globally. Local pharmaceutical companies have a strong position due to their formulation development capabilities and early investments. Additionally, the market has low price levels driven by intense competition. Although India ranks tenth globally in terms of value, it is ranked third in volumes. These characteristics create both opportunities and challenges for the industry.

To understand various terms and functions of the Indian Pharmaceutical  Sector here Shuchi Nahar’s Weekend Blog brings to you the Pharma Primer in a simple and lucid language. 

INDEX:

1) Pharmaceutical Terminologies
2) How Pharma Business Functions
3) Overview of Para Filings
4) Types of Drugs
5) Diverse Business Operations in Pharma Industry
6) Key Performance Indicators
7) Key Financial Metrics
8) Porter's Five Forces Analysis

For Understanding the Pharma Sector in detail, kindly download the PDF


Disclaimer: The information provided on Shuchi Nahar’s Weekend Blog is for educational purposes only. The articles  may contain external links , references and compilation of various publicly available articles. Hence all the authors are given due credit for the same. All copyrights and trademarks of images belong to their respective owners and are used for Fair Educational Purpose only.

Twitter Handle: @shuchi_nahar

Comments

  1. swjal process industrial water solutionJune 12, 2025 at 12:34 PM

    This primer is a well‑structured, accessible guide to the Indian pharma ecosystem, clearly explaining key terminology (API, CDMOs, para‑filings), business models, drug types, and financial metrics. It effectively highlights India’s dominance in generics and volume, offering solid industry insight—though readers should note data is from Feb 2021
    Pure Water Storage and Distribution Plant for Pharma and Biotech Industry

    ReplyDelete
  2. pharmaeurasiaDecember 18, 2025 at 2:56 PM

    Very informative and well-structured Pharma Primer. Understanding core terminologies, PARA filings, business functions, and performance metrics is essential for navigating today’s competitive pharmaceutical landscape. As global collaboration becomes more important, such knowledge will be highly valuable for industry professionals preparing to engage at platforms like pharma eurasia upcoming International pharma Trade fair 2026, where Indian pharma companies, global manufacturers, CDMOs, and regulators will converge to explore partnerships and growth opportunities. This blog serves as an excellent foundation for meaningful discussions at international trade forums.International pharmaceutical exhibition and trade Fair 2026

    ReplyDelete

Post a Comment

Most Favorite Reads!

Ethanol - Demand, Production, Opportunities & Production Projections (Part-2)

-
Image
Rapid Increase in Ethanol Production Capacity Twitter Handle: @shuchi_nahar Two Different types of processes  to produce Ethanol To produce 684 crore liters of ethanol by the sugar industry by 2025-26, sugarcane equivalent to 60 LMT of surplus sugar would be diverted to ethanol. In the current sugar season, 2020-21 more than 20 LMT of sugar is estimated to be diverted. To produce 666 crore liters of ethanol/ alcohol from food grains by 2025-26, about 165 LMT of food grains would be utilized. At present damaged food grain availability is around 40 lakh tons in the country. In 2020-21 approximately 20 lakh ton maize is surplus FCI Rice is also sufficient in stock (266 LMT) and it will continue to remain robust as procurement of paddy/rice at MSP continues at expected levels. The country is producing sufficient food grains and sugar to meet the requirement for ethanol. Molasses-based distilleries have also been offered interest subvention to convert them to dual feed, to convert b...
Read more

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-2)

-
Image
Ethanol production capacities, impact on Farmers, and Government Plans Twitter Handle: @shuchi_nahar Ethanol was rarely discussed in the country about 7-8 years ago. But now ethanol has become one of the major priorities of 21st century India. The focus on ethanol is having a better impact on the environment as well as on the lives of farmers. India’s requirement of ethanol for petrol blending will increase from 173 crore liters in 2019-20 to 1,016 crore liters in 2025-26. To enable the rollout of ethanol production across India, ethanol may be supplied from surplus to deficit states based on the requirements to ensure uniform availability of ethanol blends in the country. To achieve the Modi Administration’s E-20 blending goal by ethanol supply year (ESY) (December-November) 2025, India would need to procure approximately 11 billion liters (BL) of ethanol for blending with petroleum. As of November 2021, India’s concentrated ethanol production capacity totaled slightly above 6 bi...
Read more

Nutraceuticals - The Next Gem of Healthcare Sector

-
Image
     Nutraceuticals - The Next Gem of Healthcare Sector Shuchi.P.Nahar Twitter: shuchi_nahar What is Nutraceuticals? The term ‘nutraceuticals’ was firstly used in the late 1980s to describe food products that have a medicinal benefit. This fast-growing sector includes functional foods (such as vitamin-enriched products), nutritional supplements, sport drinks, and medically formulated foods.  Nutraceuticals and its Division Figure 1: The diagram showing the various divisions of Nutraceuticals  Scope Nutraceuticals is expected to play a central role in preventative healthcare. The logic seems simple - an ageing population gives rise to lifestyle-related diseases, whose impact can be lessened by making healthier choices earlier in life. This convergence of medicine, food and technology is likely to create a battleground in which food and pharma companies compete for dominance of the sector. Successful companies will have to hit the bullseye in six main areas: techn...
Read more

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-1)

-
Image
Ethanol - The next big tailwind story Twitter Handle: @shuchi_nahar Introduction Ethanol , also called ethyl alcohol, drinking alcohol, or simply alcohol is simple alcohol that is often abbreviated as EtOH. Ethanol production in India is mainly dominated by sugary feedstock, and C-heavy molasses available from sugar mills. Ethanol produced by fermentation of renewable food crops such as sugarcane, maize, wheat, sorghum, beet, and other starches is called bioethanol, and it is the eco-friendly alternative biofuel. The product is primarily used as a solvent in various industries such as: In addition, ethanol is gaining popularity as an efficient alternative fuel. It has significant penetration in the major end-use industries such as automotive, foods and beverages, chemicals, personal care and cosmetics, and pharmaceuticals. According to the reports, the global ethanol market is projected to grow at a robust CAGR of 4.5% to reach USD 117 Billion by the end of 2027. The primary factors fa...
Read more

Laurus Labs - Result Update Q4FY21 & Full Year FY21

-
Image
Laurus Labs - Result Update Q4FY21 & Full Year FY21 Twitter Handle: @shuchi_nahar Laurus Labs Limited on 30th April 2021 announced its Q4FY21 and full-year results.  Laurus Lab performed extremely well consecutive in the 4th Quarter of FY21. The company did a robust growth in all three segments. Having a healthy order book for FY 22. Consolidated revenue for the quarter increased by 70% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 297 Crs. for the quarter. Generic API division showcased a robust growth of 61% YoY. Anti Viral segment recorded a robust growth of 70% YoY. Revenue Showcased a healthy growth of 102% YoY. The growth was led by higher LMIC Market volumes and increased volumes from North America and EU Commenced marketing of in-licensed products in the USA to leverage front-end capabilities. Custom Synthesis division recorded a strong growth of 35% YoY. Capacity Expan...
Read more